Invatec gains access to US market with ev3 deal:
This article was originally published in Clinica
Italian company Invatec has appointed Plymouth, Minnesota-based ev3 as exclusive distributor of its endovascular products in the US. The deal represents Brescia-based company's entry into this significant market for the first time. Invatec will also team up with ev3 to commercialise Invatec's new technology aimed at the embolic protection and thrombectomy markets. ev3, a young, privately-held company involved in developing endovascular technologies, will see its product line expand with this new alliance, particularly in the areas of peripheral angioplasty balloon catheters, balloon-expandable and self-expanding stent systems and guidewires.